Resistin, secreted from adipocytes, causes
insulin resistance and diabetes in rodents. To determine the relation between serum
resistin and
diabetic microangiopathies in humans, we analyzed 238 Japanese T2DM subjects. Mean serum
resistin was higher in subjects with either advanced retinopathy (preproliferative or proliferative) (P=0.0130), advanced nephropathy (stage III or IV) (P=0.0151), or neuropathy (P=0.0013). Simple regression analysis showed that serum
resistin was positively correlated with retinopathy stage (P=0.0212), nephropathy stage (P=0.0052), and neuropathy (P=0.0013). Multiple regression analysis adjusted for age, gender, and BMI, revealed that serum
resistin was correlated with retinopathy stage (P=0.0144), nephropathy stage (P=0.0111), and neuropathy (P=0.0053). Serum
resistin was positively correlated with the number of advanced microangiopathies, independent of age, gender, BMI, and either the duration of T2DM (P=0.0318) or serum
creatinine (P=0.0092). Therefore, serum
resistin was positively correlated with the severity of microangiopathies in T2DM.